Jianlin Xu

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 152 citations · Full text

Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer

Zhi‐Yun Jiang, M. Wang, Jianlin Xu · Life Sciences · 2017 · 128 citations

Medicine, Multiple Pulmonary Nodule, Diagnostic Value +11

Multi-scale integrative analyses identify THBS2⁺ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

Haitang Yang, Beibei Sun, Liwen Fan et al. · Theranostics · 2022 · 105 citations · Full text

Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma

Fangfei Qian, Wenjia Yang, Rui Wang et al. · Journal of Thoracic and Cardiovascular Surgery · 2017 · 102 citations · Full text

Surgical Oncology, Medicine, Pathology +8

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

Jianlin Xu, Bo Jin, Tianqing Chu et al. · Lung Cancer · 2016 · 94 citations

Oncology, Medicine, Pathology +8